Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer

Hubin Yin1, Weiyang He2, Yunhai Li3

  • 1Department of Urology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.

Human Pathology
|November 21, 2018
PubMed

Insights

Dual-specificity phosphatase 2 (DUSP2) is downregulated in bladder cancer, correlating with advanced stages and poor survival. Reduced DUSP2 expression indicates a worse prognosis for bladder cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Dual-specificity phosphatase 2 (DUSP2) regulates mitogen-activated protein kinases (MAPKs).
  • DUSP2's role in bladder cancer pathogenesis is currently unknown.
  • DUSP2 is implicated in immune processes, inflammation, and cancer progression.

Purpose of the Study:

  • To investigate the expression and prognostic significance of DUSP2 in bladder cancer.
  • To determine if DUSP2 is associated with bladder cancer progression and patient survival.

Main Methods:

  • Analysis of DUSP2 expression in bladder cancer tissues and cell lines.
  • Correlation of DUSP2 levels with clinicopathological features (grade, stage, subtype) in The Cancer Genome Atlas and tissue microarray cohorts.
  • Kaplan-Meier and Cox regression analyses to assess the impact of DUSP2 on overall and recurrence-free survival.

Main Results:

  • DUSP2 expression was significantly downregulated in bladder cancer tissues and cell lines compared to normal controls.
  • Lower DUSP2 expression correlated with higher pathological grade, advanced AJCC/TNM stage, and specific subtypes.
  • Reduced DUSP2 levels were associated with shorter overall survival and recurrence-free survival in both patient cohorts.

Conclusions:

  • DUSP2 is downregulated in bladder cancer and serves as a potential biomarker for disease progression.
  • Reduced DUSP2 expression is an independent predictor of poor survival prognosis in bladder cancer patients.
  • Further research is warranted to elucidate DUSP2's tumor-suppressive function in bladder cancer.

Related Concept Videos

Line Loss01:10

Line Loss

The different configurations of source-load connections include wye (star) and delta connections. The relationship between line and phase voltages and currents varies depending on the configuration. When the source is supplying power, it is transmitted through the wires to the load, and during this transmission, some power is absorbed by the wires, leading to line loss.
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
541
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.8K
Reducing Line Loss01:18

Reducing Line Loss

In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
391
Urinary Bladder01:23

Urinary Bladder

The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
3.4K